BAJAJHCARE
NSEBajaj Healthcare Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹348.70
1.40 (0.40%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.10K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
55.3
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹272.35+28.0%
52W High₹552.6-36.9%
Current Price
₹348.70
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹278.96
Upper Circuit₹418.44
Reference Price
₹348.70
Investment Checklist
Cup and Handle on 1D — target ₹402.03
Volume divergence: Bullish (price down, volume up)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
3-day momentum: +5.2% — strong upward pressure
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
77%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
329.19
EMA50
320.38
EMA200
367.48
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs4
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹363.25
₹386.45
₹393.45
₹399.45
₹419.19
Support (Below)
₹348.00
₹327.58
₹319.00
₹314.90
₹287.40
Volume Analysis
TrendINCREASING
Change+621.40%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹345.21
3% Risk₹338.24
5% Risk₹331.26
7% Risk (Custom)
₹324.29Technical Levels
1x ATR (Volatility)₹333.63
2x ATR (Swing)₹318.56
3x ATR (Trend)₹303.49
Immediate Support₹348.00
Moving Averages
EMA 9 (Short-term)₹339.47
EMA 20 (Medium-term)₹329.19
EMA 50 (Trend)₹320.38
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹122.8 Cr | ₹154.5 Cr | ₹148.8 Cr | ₹161.2 Cr |
| Net Profit | ₹11.7 Cr | ₹11.2 Cr | ₹11.8 Cr | ₹15.7 Cr |
| EPS | ₹3.65 | — | ₹3.74 | ₹4.96 |
| Operating Profit | ₹24 Cr | ₹25.3 Cr | ₹25.4 Cr | ₹32.3 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Bajaj Healthcare Limited | ₹348.70 | -0.40% | 55.3 | ₹1.10K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 19 Sept 2025 | Dividend - Re 1 Per Share | DIVIDEND |
| 23 Sept 2024 | Annual General Meeting/Dividend - Re 1 Per Share | AGM |
| 22 Sept 2023 | Annual General Meeting/Dividend - Re 1 Per Share | AGM |
| 22 Sept 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for BAJAJHCARE
View AllNEWS
positive
Business Standard - Markets 11d ago
Bajaj Healthcare surges after secures SEC recommendation for Cenobamate tablets
Bajaj Healthcare soared 12.98% to Rs 345 after the company said that Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) has recommended for grant of approval for manufacturing and marketing of Cenobamate Tablets.
BAJAJHCAREHCGHCG-REHEALTHCARESILFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 12d ago
Omaxe Ltd leads gainers in 'B' group
Bajaj Healthcare Ltd, Prakash Pipes Ltd, Gujarat Natural Resources Ltd and Krishival Foods Ltd Partly Paidup are among the other gainers in the BSE's 'B' group today, 29 June 2026.
BAJAJHCAREBSEGNRLHCGHCG-REHEALTHCAREKRISHIVALLTFOODSMOHEALTHOMAXEPPLPRAKASHCapital GoodsFast Moving Consumer Goods
NEWS
positive
Business Standard - Markets 12d ago
Stock Alert: Aurobindo Pharma, Likhitha Infra, Vikran Engineering, Ashoka Buildcon, Bajaj Healthcare
Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh.
ASHOKAAUROPHARMABAJAJHCAREHCGHCG-REHEALTHCAREHGINFRAINFRALIKHITHAMBELVIKRANConstructionFinancial Services